Ann Hermone
Impact in
- Neurology top 5%
- Botulinum Toxin and Related Neurological Disorders
- Neurological disorders and treatments
- Toxicology top 10%
Papers in
-
- Biochemical and Structural Characterization 4
- Cancer therapeutics and mechanisms 2
- Bacillus and Francisella bacterial research 2
-
- Botulinum Toxin and Related Neurological Disorders 6
- Parkinson's Disease Mechanisms and Treatments 3
- Co-authors
- Rick Gussio (14 shared papers)James C. Burnett (13 shared papers)Connor F. McGrath (11 shared papers)Tam Luong Nguyen (9 shared papers)Daniel Zaharevitz (5 shared papers)Peter Wipf (6 shared papers)Sina Bavari (9 shared papers)James J. Schmidt (7 shared papers)
- Journals
- Journal of Medicinal Chemistry (3 papers)Molecular Cancer Therapeutics (1 paper)Journal of Structural Biology (1 paper)Bioorganic & Medicinal Chemistry (1 paper)Nature Structural & Molecular Biology (1 paper)
- Partner nations
- United StatesSerbiaFrance
In The Last Decade
Ann Hermone
15 papers receiving 734 citations
Peers
Comparison fields: 5 of 68
- Neurology 237
- Toxicology 26
- Organic Chemistry 216
- Molecular Biology 418
- Cell Biology 75
Countries citing papers authored by Ann Hermone
This map shows the geographic impact of Ann Hermone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Hermone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Hermone more than expected).
Fields of papers citing papers by Ann Hermone
This network shows the impact of papers produced by Ann Hermone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Hermone. The network helps show where Ann Hermone may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann Hermone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 254 | |
| 2 | 2003 | 118 | |
| 3 | 2006 | 85 | |
| 4 | 2003 | 77 | |
| 5 | 2007 | 43 | |
| 6 | 2009 | 37 | |
| 7 | 2011 | 35 | |
| 8 | 2004 | 34 | |
| 9 | 2008 | 26 | |
| 10 | 2005 | 18 | |
| 11 | 2017 | 13 | |
| 12 | 2005 | 10 | |
| 13 | 2019 | 5 | |
| 14 | 2007 | 3 | |
| 15 | 2013 | 1 |
About Ann Hermone
Ann Hermone is a scholar working on Molecular Biology, Neurology, Organic Chemistry, Oncology and Genetics, having authored 15 papers that have together received 759 indexed citations. Recurring topics across this work include Botulinum Toxin and Related Neurological Disorders (6 papers), Biochemical and Structural Characterization (4 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Cancer Treatment and Pharmacology (2 papers), Cancer therapeutics and mechanisms (2 papers), Bacterial Genetics and Biotechnology (2 papers), Synthesis and biological activity (2 papers) and Bacillus and Francisella bacterial research (2 papers). The work is most often cited by research in Neurology (237 citations), Toxicology (26 citations), Organic Chemistry (216 citations), Molecular Biology (418 citations) and Cell Biology (75 citations). Ann Hermone has collaborated with scholars based in United States, Serbia and France. Frequent co-authors include Rick Gussio, James C. Burnett, Connor F. McGrath, Tam Luong Nguyen, Daniel Zaharevitz, Peter Wipf, Sina Bavari, James J. Schmidt, Ernest Hamel and Billy W. Day. Their work appears in journals such as Journal of Medicinal Chemistry, Molecular Cancer Therapeutics, Journal of Structural Biology, Bioorganic & Medicinal Chemistry and Nature Structural & Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.